Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Nicotinic Agonist Effects on BMI and Neuronal Response [Phase 1]
Phase 1 trial investigating nicotinic agonist effects on BMI and neuronal response in obesity.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients [Phase 3]
A Phase 3 trial report on the efficacy and safety of liraglutide for weight loss in obese and overweight patients has been completed.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Reprometabolic Syndrome Mediates Subfertility in Obesity [NA]
This clinical trial update discusses reprometabolic syndrome as a mediator of subfertility in obesity. The trial's results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Targeting Body Image Among Women of Higher Body Weight [NA]
A completed clinical trial studying targeting body image among women with higher body weight, related to obesity and overweight conditions.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Detemir Energy Expenditure Study [Phase 4]
A Phase 4 clinical trial update for detemir assessing energy expenditure in individuals with type 2 diabetes mellitus and obesity has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2023-05-31Clinical Trial Update: Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus [Phase 2]
Phase 2 trial evaluating ox bile-conjugated bile acids sodium in adults with type 2 diabetes mellitus and obesity; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Texting for Mobility in Overweight/Obese Adults With Peripheral Artery Disease [NA]
Clinical trial update on texting intervention for mobility in adults with overweight/obesity and peripheral artery disease; study completed …
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in Obesity [Phase 4]
Phase 4 trial update comparing dapagliflozin/metformin XR versus monotherapies on anthropometric indicators in obesity.
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Utilizing Protein During Weight Loss to Impact Physical Function [NA]
A completed clinical trial investigating the impact of utilizing a protein during weight loss on physical function in individuals with obesi…
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: Endothelial Dysfunction in Obese Children [NA]
A completed clinical trial studying endothelial dysfunction in obese children has results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: Promoting The Self-Regulation Of Energy Intake [NA]
A completed clinical trial investigating self-regulation of energy intake in obesity; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: Breastfeeding and Exercise for Healthy Infants and Postpartum Moms Too! [NA]
A completed clinical trial evaluating breastfeeding and exercise for healthy infants and postpartum moms; conditions include osteoporosis, o…
-
EMA approval · 2023-05-10EMA Authorised: Xenical (orlistat) — CHEPLAPHARM Arzneimittel GmbH
European Medicines Agency authorises Xenical (orlistat) for obesity through CHEPLAPHARM Arzneimittel GmbH.
-
FDA approval · 2023-05-09FDA Approved: PHENTERMINE AND TOPIRAMATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for phentermine and topiramate, a weight-management medication. This action…
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Dose-Ranging Study of SKF7® for Obesity [Phase 2]
Phase 2 dose-ranging trial of SKF7 for obesity has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy [Phase 2, Phase 3]
A Phase 2/3 clinical trial investigating behavioral and pharmacologic maintenance therapy for binge eating disorder and obesity has complete…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Brain Dopamine Function in Human Obesity [EARLY_Phase 1]
Early-phase clinical trial updating brain dopamine function in humans related to obesity; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: Effect of a Unique Web-based Behaviour Change Program on Weight Loss and Cardiovascular Risk Factors [Phase 2]
Phase 2 trial evaluating a web-based behaviour change program for weight loss and cardiovascular risk factors in obesity; results posted aft…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: The GEM (Goals for Eating and Moving) Study [NA]
Completed clinical trial update for the GEM study focused on weight gain and obesity; results posted in 2023.
-
CLINICAL_TRIALS research · 2023-04-27Clinical Trial Update: Characterization of Bile Acid Pathway in Obesity [NA]
Clinical trial summary detailing characterization of the bile acid pathway in obesity; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Healthy Mom Zone: A Gestational Weight Gain Management Intervention [NA]
A completed clinical trial evaluating a gestational weight gain management intervention for overweight pregnant individuals; results posted …
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight [Phase 3]
This clinical trial update reports Phase 3 results for tirzepatide in adults with obesity or overweight, with results posted on 2023-04-24.
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity [Phase 4]
Phase 4 trial update evaluating efficacy and safety of sibutramin-containing drugs in patients with obesity.
-
FDA approval · 2023-04-20FDA Approved: SAXENDA — Supplemental Application (Novo Nordisk)
The FDA approves a supplemental application for SAXENDA (liraglutide) submitted by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery [Phase 3]
A Phase 3 trial evaluating Preoperative Hexakapron shows reduced bleeding in bariatric surgery, though the study was terminated.